SCHEMBL5283848

SCHEMBL5283848

CCCCCN(NCc1ccc2c(c1)CCC(C)(C)O2)C(=O)CCOC(=O)N(c1ccccc1-c1ccccc1)N1CC[CH]CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAGLA Q9Y4D2 7/20 0.35
ABHD6 Q9BV23 2/20 0.35
KDM1A O60341 1/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
MGAM O43451 5/20 0.34
GAA P10253 5/20 0.34
SI P14410 5/20 0.34
MGAM2 Q2M2H8 5/20 0.34
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
KCNH2 Q12809 1/20 0.33
HTR2A P28223 1/20 0.32
GHSR Q92847 1/20 0.32
OPRM1 P35372 1/20 0.32
CTSB P07858 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5282202 0.90 CHRM5 (0.38) KDM1AMAOAMAOB
SCHEMBL6021930 0.78 LTB4R2 (0.34) CYP3A4OPRM1
SCHEMBL6022345 0.76 CYP1A2 (0.37) CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL5276883 0.67 CHRM3 (0.33)
SCHEMBL6022322 0.66 ADRB2 (0.35) KCNH2OPRM1
SCHEMBL4691377 0.65 KMT2A (0.36) KMT2A
SCHEMBL6021999 0.65 LTB4R2 (0.33) HTR2A
SCHEMBL5801465 0.65 MEN1 (0.34) GAAMEN1KMT2A
SCHEMBL5285440 0.65 CHRM3 (0.58)
SCHEMBL5803533 0.64 ERCC1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1866284-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS Theravance, Inc. (US) 2007-12-19 EP disclosed
WO-2006099167-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS THERAVANCE, INC. (US) 2006-09-21 WO disclosed